Gait speed is predictive of adverse cardiac intervention outcomes
by Bruce Sylvester: Gait speed is an independent predictor of adverse outcomes after cardiac surgery, researchers reported on May 11, 2016 in JAMA Cardiology.
by Bruce Sylvester: Gait speed is an independent predictor of adverse outcomes after cardiac surgery, researchers reported on May 11, 2016 in JAMA Cardiology.
by Bruce Sylvester: Psoriasis appears to be associated with type 2 diabetes, body mass index and obesity, researchers from a twin study reported on April 27, 2016 in… read more.
by Bruce Sylvester: Persistent, very poorly controlled (VPC) disease remains highly prevalent after 10 years of standard treatment among patients with severe or difficult-to-treat asthma, researchers reported on… read more.
by Bruce Sylvester: During three years following bariatric surgery, a majority of patients achieved improvement in pain, physical function, and walk time, researchers reported on April 5 2016… read more.
Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.
Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.
Dr Sridhar Chaganti, University Hospital, Birmingham NHS Foundation Trust, UK. by Christine Clark: In general the outcomes of treatment for diffuse large B-cell lymphoma (DLBCL) are good –… read more.
Professor Karl Peggs, University College, London. by Christine Clark: There are numerous regimens for salvage treatment of Hodgkin lymphoma and all are associated with an overall response rate… read more.
Rethinking risk for better outcomes in ASCT by Christine Clark Dr Craig Moskowitz, Memorial Sloan Kettering Cancer Center, NY, USA. Patient populations are changing – before 2010 all… read more.
Allogeneic stem cell transplantation: still a role in CLL/lymphoma? by Christine Clark Professor Peter Dreger, Heidelberg University Hospital, Germany. The goal of allogeneic transplant therapy is to provide… read more.
Charlotte Pawlyn and John R Jones (both of Institute of Cancer Research, London) and Ruth de Tute, St James’s University Hospital, Leeds. by Maria Dalby: Quadruplet therapy with… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.